Hetero has launched its generic semaglutide portfolio in overseas markets even as it is awaiting regulatory approvals in India. The launch represents the beginning of a strategic, multi-year global ...

Liraglutide is used in the treatment of chronic weight management. Mittal added, "GLP-1 therapies represent a significant growth driver for the company, with the United States being an important ...

A newly-formed Canadian pharmaceutical company is vying to break into the market with a generic version of one of the most well-known prescription drugs in the world: Ozempic. “You could say we’re ...

Access to affordable medicines remains one of the biggest challenges in healthcare systems worldwide, especially in low- and middle-income countries. In India, where a significant portion of medical ...

Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries Weight-loss jabs such as Wegovy could be made for just $3 a month, according to new ...

Over the last year, Sanofi has been busy reshaping itself to focus more on innovative drugs, including selling a controlling stake in its former consumer business and using those proceeds to strike a ...

On Feb. 27, reporters Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are saying about the health risks and benefits and how it ...

Oral anti-obesity formulations will be the next growth lever in Danish drugmaker Novo Nordisk's India strategy, following the 2025 launches of its blockbuster diabetes and obesity brands Ozempic and ...

For months, President Donald Trump and his aides touted efforts to lower prescription drug prices for Americans. Now consumers can check prices at the recently launched website TrumpRx.gov. "This is a ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...